Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Austin, Texas, Company Raises $14 Million to Market Device to Monitor HIV/AIDS Patients' CD4+ T-Cell Levels

October 1, 2004

Austin, Texas-based LabNow has raised $14 million in a first round of fundraising to bring to market a new technology that monitors HIV/AIDS patients' CD4+ T cell levels, the Austin American-Statesman reports. The device, which is expected to be about the size of a toaster, is a smaller, less-expensive version of the CD4+ T cell testing device that currently helps doctors effectively prescribe medications to HIV-positive people, according to the American-Statesman. The device currently used to measure CD4+ T cells is the size of a refrigerator and costs $75,000. LabNow plans to sell the device for about $750 to clinics in developing countries -- particularly China, Mexico and South Africa -- and to not-for-profit groups that work with HIV/AIDS issues and hopes to subsidize most of the cost of the device and "practically give them away," LabNow CEO Richard Hawkins said. Hawkins said he hopes to make the device available by July 2005 and manufacture 20,000 in the first year. Billionaire George Soros is the company's largest backer, investing $7 million in the project, while the Austin Ventures invested more than $3 million. The University of Texas, which developed the testing method, owns 10.5% of LabNow and will collect royalties from sales (Rayasam, Austin American-Statesman, 9/30).

Back to other news for October 1, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement